Inventors – All Technologies Are not Worth Billions

Working in the IP/Technology Commercialization and Out-Licensing domain makes you assess and evaluate the commercial viability of numerous IP backed inventions across technology domains. Apart from learning about and assessing new technologies, we also tend to learn quite a lot about Inventors’ mindset, specifically about their perspective of their own inventions. This article relates to […]

Inventors – All Technologies Are not Worth Billions

Working in the IP/Technology Commercialization and Out-Licensing domain makes you assess and evaluate the commercial viability of numerous IP backed inventions across technology domains. Apart from learning about and assessing new technologies, we also tend to learn quite a lot about Inventors’ mindset, specifically about their perspective of their own inventions. This article relates to […]

Food Market making Profit from Climatic Changes

Climatic changes being a source of making a profit for food crop manufacturers. Adverse changes in climate have triggered the ecosystems affecting crops, livestock, fisheries and forests, and the billions of people whose livelihoods depend on them. Extreme climate events (especially hotter, drier conditions in semi-arid regions) are likely to slash yields for maize, wheat, […]

Internatioinal Patent Protection in Electronics & IT (SIP – EIT) Scheme by DIT

It is enriching to hear and read so much of focus going these days into Innovation at Grass Root and Startup level. With initiatives being taken at all levels by Stakeholders including FICCI, MSME, DIT, and NASSCOM, the next wave of the so-called Start-up innovation can really be envisioned. As has correctly been stated by […]

Hi-tech Patent Licensing Trends

Ever since Software Patents have got easier to get a grant for, protection of computer-readable medium claims on a storable media has enforced the Intellectual Property Rights to a much higher level than a software company can have when compared with the counterpart System and Method claims. Although most countries, unlike the US, are still […]

Indian Pharmaceutical Industry Licensing Deals: Case Studies

Glenmark Pharmaceuticals Glenmark, research-driven, global, integrated pharmaceutical company with Research Focus on Inflammatory Diseases, Metabolic Disorders and Pain has a presence in over 80 countries around the world. The Company has a proven track record of entering into Licensing deals with Big Pharma and entered into Outlicensing deals in 2004 with Forest laboratories for Oglemilast, […]